Video Buzz v1
Highlighting streaming videos you should be watching
RelatedLinks
March 20th
March 2nd
February 6th
July 11th
June 16th
- http://www.pub medcentral.nih .gov/picrender .fcgi?artid=21 69297&blobtype =pdf: Beta Adrenergic Receptors in Keratinocytes
June 10th
- Beta Adrenergic Receptors in Keratinocytes: Beta Adrenergic Receptors in Keratinocytes
- kinase norepinephrine eczema - Google Search: Beta Adrenergic Receptors in Keratinocytes-
April 23rd
- cAMP-Binding Protein Epac Induces Cardiomyocyte Hypertrophy -- Morel et al. 97 (12): 1296 -- Circulation Research
- ScienceDirect - Trends in Molecular Medicine : AKAP signaling complexes: getting to the heart of the matter
- The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmoduli n kinase signalling pathway in rat cardiac myocytes -- Pereira et al. 583 (2): 685 -- The Journal of Physiology Online
- Going to cAMP just got more complicated -- Bers 583 (2): 415 -- The Journal of Physiology Online
- EPAC regulation of cardiac EC coupling -- Smrcka et al. 584 (3): 1029 -- The Journal of Physiology Online
- Epac Mediates {beta}-Adrener gic Receptor-Induc ed Cardiomyocyte Hypertrophy -- Métrich et al., 10.1161/CIRCRE SAHA.107.16494 7 -- Circulation Research
April 11th
November 29th
- Stress hormones and post-traumatic stress disorder in civilian trauma victims: a longitudinal study. Part II: The adrenergic response: adrenergic response to civilian traumatic experiences and the relationship to PTSD
RelatedImages
Video Buzz > Adrenergic
No Matching Video
No video for Adrenergic is available at this time.
Related Adrenergic News
Aton Pharma CEO Mike Wells Named Ernst & Young Entrepreneur Of The ... - CNBC
announced today that its Chief Executive Officer, Michael G. Wells, has received the Ernst & Young Entrepreneur Of The Year(R) 2009 Award in the emerging companies category in New Jersey. According to Ernst & Young LLP, the award recognizes ...
Santhera's FJORD Phase IIb Study Demonstrates Efficacy of JP-1730 ... - Phramalive.com
Liestal, Switzerland, June 30, 2009 - Santhera Pharmaceuticals (SIX: SANN), a Swiss specialty pharmaceutical company focused on neuromuscular diseases, announced today positive data from its Phase IIb study (FJORD). The key finding of the trial is ...
Cardioxyl Pharmaceuticals Initiates Phase I/IIa Study in Heart Failure - Market Wire
HUNT VALLEY, MD--(Marketwire - July 1, 2009) - Cardioxyl Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing therapeutic agents for the treatment of cardiovascular disease, today announced the initiation of a Phase I/IIa dose ...
Cardioxyl Pharmaceuticals Initiates Phase I/IIa Study in Heart Failure ... - PR Inside
HUNT VALLEY, MD -- (Marketwire) -- 07/01/09 -- Cardioxyl Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing therapeutic agents for the treatment of cardiovascular disease, today announced the initiation of a Phase I/IIa dose ...
Adrenergic Podcasts
Do you prefer to listen to your adrenergic gossip? Check out Podzy Podcast Directory > Adrenergic.
Adrenergic Products
Looking for adrenergic related products, then look no further. Try our new Adrenergic Shop.